Physician profile
Jill Lynn Hessler
NPI 1922043074
$114,462.74
in general payments reported to CMS, 2019-2025
8 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what 91% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $11K · 2021: $17K · 2022: $32K · 2023: $13K · 2024: $25K · 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $6,563 · Food and Beverage: $5,768 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,620 · Education: $59.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,135.00 |
| Travel and Lodging | $6,562.95 |
| Food and Beverage | $5,767.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,620.40 |
| Education | $59.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $44,993.99 | 2019-2023 | |
| Abbvie INC. | $33,397.16 | 2023-2025 | |
| Galderma Laboratories, L.P. | $31,829.40 | 2019-2025 | Dysport |
| Merz North America, INC. | $3,908.63 | 2019-2025 | Xeomin |
| Revance Therapeutics, INC. | $237.40 | 2024-2025 | Daxxify |
| Polarityte, INC. | $50.00 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $23.47 | 2022 | |
| Kls-Martin L.P. | $22.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Hessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.